| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |